PE20090066A1 - Composiciones farmaceuticas en base a granulos de un derivado de azidocitidina y un copolimero de bloques y procedimiento de preparacion - Google Patents

Composiciones farmaceuticas en base a granulos de un derivado de azidocitidina y un copolimero de bloques y procedimiento de preparacion

Info

Publication number
PE20090066A1
PE20090066A1 PE2008000545A PE2008000545A PE20090066A1 PE 20090066 A1 PE20090066 A1 PE 20090066A1 PE 2008000545 A PE2008000545 A PE 2008000545A PE 2008000545 A PE2008000545 A PE 2008000545A PE 20090066 A1 PE20090066 A1 PE 20090066A1
Authority
PE
Peru
Prior art keywords
pharmaceutical compositions
preparation procedure
granules
azidocitidine
derivative
Prior art date
Application number
PE2008000545A
Other languages
English (en)
Inventor
Kondamraj Birudaraj
Michael Thomas Brandl
Felix Sana
Dimitrios Stefanidis
Shridar Hegde
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20090066A1 publication Critical patent/PE20090066A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

SE REFIERE A COMPOSICIONES FARMACEUTICAS QUE COMPRENDEN: a)GRANULOS QUE CONTIENEN, 50-70% (w/w) DE SAL CLORHIDRATO DE ISOBUTIRATO DE (2R,3S, -4R,5R)-5-(4-AMINO-2-OXO-2H-PIRIMIDIN-1-IL)-2-AZIDO-3,4-bis-ISOBUTIRILOXI-TETRAHIDRO-FURAN-2-ILMETILO Y 5-20% (w/w) DE UN POLOXAMERO 188; OPTENIDO POR GRANULACION HUMEDA; b)UN COPOLIMERO DE BLOQUES DE POLIETILENGLICOL (PEG)/POLIPROPILENGLICOL (PPG); c)UN DILUYENTE, TAL COMO MANITA O CELULOSA MICROCRISTALINA; DESINTEGRANTE, TAL COMO CROSCARMELOSA; UN LUBRICANTE, TAL COMO ESTERATO DE MAGNESIO Y UN MATERIAL DE RECUBRIMIENTO, TAL COMO OPADRY. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION. DICHA COMPOSICION SOLIDA TIENE UN PESO TOTAL DE 100 Y 1200 mg
PE2008000545A 2007-03-29 2008-03-26 Composiciones farmaceuticas en base a granulos de un derivado de azidocitidina y un copolimero de bloques y procedimiento de preparacion PE20090066A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92058607P 2007-03-29 2007-03-29

Publications (1)

Publication Number Publication Date
PE20090066A1 true PE20090066A1 (es) 2009-02-13

Family

ID=39541351

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008000545A PE20090066A1 (es) 2007-03-29 2008-03-26 Composiciones farmaceuticas en base a granulos de un derivado de azidocitidina y un copolimero de bloques y procedimiento de preparacion

Country Status (12)

Country Link
US (1) US7893037B2 (es)
EP (1) EP2142178B1 (es)
JP (1) JP2010522705A (es)
CN (1) CN101668515B (es)
AR (1) AR065853A1 (es)
AT (1) ATE540672T1 (es)
CA (1) CA2682638C (es)
CL (1) CL2008000861A1 (es)
ES (1) ES2377760T3 (es)
PE (1) PE20090066A1 (es)
TW (1) TW200909006A (es)
WO (1) WO2008119659A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2455068A1 (en) * 2010-11-09 2012-05-23 F. Hoffmann-La Roche AG Pharmaceutical composition for treating HCV infections
US8889159B2 (en) * 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
KR20230130175A (ko) 2014-12-26 2023-09-11 에모리 유니버시티 N4-하이드록시시티딘, 이와 관련된 유도체 및 이의 항 바이러스적 용도
AU2018378832B9 (en) * 2017-12-07 2021-05-27 Emory University N4-hydroxycytidine and derivatives and anti-viral uses related thereto
CN112957335B (zh) * 2021-02-23 2022-10-04 上海纳为生物技术有限公司 一种乙酰氨基葡萄糖口腔崩解片及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ230497A (en) * 1988-09-02 1992-05-26 Du Pont Layered, granular water-soluble or water-dispersible pesticide
AU2256702A (en) * 2000-12-01 2002-06-11 Kyowa Hakko Kogyo Kk Composition improved in solubility or oral absorbability
TWI332507B (en) * 2002-11-19 2010-11-01 Hoffmann La Roche Antiviral nucleoside derivatives
EP1664074A2 (en) * 2003-09-11 2006-06-07 F.Hoffmann-La Roche Ag Polymorphic nucleoside compounds
EP1701704A2 (en) * 2003-12-31 2006-09-20 Pfizer Products Inc. Solid compositions of low-solubility drugs and poloxamers
ATE482690T1 (de) * 2005-12-14 2010-10-15 Hoffmann La Roche Hcv-prodrug-formulierung

Also Published As

Publication number Publication date
EP2142178B1 (en) 2012-01-11
CN101668515B (zh) 2013-03-20
EP2142178A2 (en) 2010-01-13
CA2682638A1 (en) 2008-10-09
CA2682638C (en) 2012-07-17
CL2008000861A1 (es) 2008-11-07
US20080260826A1 (en) 2008-10-23
AR065853A1 (es) 2009-07-08
WO2008119659A2 (en) 2008-10-09
ATE540672T1 (de) 2012-01-15
CN101668515A (zh) 2010-03-10
US7893037B2 (en) 2011-02-22
JP2010522705A (ja) 2010-07-08
TW200909006A (en) 2009-03-01
ES2377760T3 (es) 2012-03-30
WO2008119659A3 (en) 2009-03-05

Similar Documents

Publication Publication Date Title
CY1126116T1 (el) Φαρμακευτικες συνθεσεις αποτελουμενες απο νιλοτινιμπη
ECSP088528A (es) Formulación de profármacos para el vhc
TW200621313A (en) Pharmaceutical compositions
EA200901277A1 (ru) Фармацевтические составы, содержащие пропиленгликольгидрат дапаглифлозина
PE20061449A1 (es) Composiciones farmaceuticas comprendiendo imatinib y un retardador de liberacion
CY1113395T1 (el) Σταθερη φαρμακευτικη συνθεση που περιεχει πυριμιδινη-σουλφαμιδη
EA201001852A1 (ru) Твердые фармацевтические составы, содержащие bibw 2992
PE20090066A1 (es) Composiciones farmaceuticas en base a granulos de un derivado de azidocitidina y un copolimero de bloques y procedimiento de preparacion
BRPI0615135A2 (pt) composições de fármacos contendo matrizes de hipromelose de liberação controlada
AR060838A1 (es) Formulaciones de dosificacion solida
RU2008135718A (ru) Композиции клопидогреля бисульфата
AR061093A1 (es) Composiciones de calcio
MX2009008028A (es) Agentes antiparasitarios.
UA109627C2 (uk) Композиції тетрациклінових сполук для орального введення та ін'єкцій
CL2007002812A1 (es) Compuestos derivados de quinolina; composicion farmaceutica, utiles para inhibir el vih.
NO20083183L (no) Fast farmasoytisk sammensetning inneholdende irbesartan
GEP20125392B (en) Tricyclic compounds and pharmaceutical use thereof
PE20120990A1 (es) Formulaciones de alisquireno e hidroclorotiazida
AR088838A1 (es) Derivados de imidazol como inhibidores del virus de la hepatitis c
EA200970690A1 (ru) Моносоль малеиновой кислоты антивирусного агента и содержащая ее фармацевтическая композиция
EA201001125A1 (ru) Фармацевтические композиции, включающие n-[2-(диэтиламино)этил]-5-[(5-фтор-1,2-дигидро-2-оксо-3н-индол-3-илиден)метил]-2,4-диметил-1н-пиррол-3-карбоксамид
EA201100104A1 (ru) Фармацевтическая композиция, содержащая статин
EA201170583A1 (ru) Новая композиция для лечения эссенциальной тромбоцитемии
ATE508737T1 (de) Clopidogrel-hydrogensulfat von polymorph 1 form enthaltende pharmazeutische zusammensetzung
EA200401218A1 (ru) Фармацевтическая композиция, содержащая фозиноприл

Legal Events

Date Code Title Description
FD Application declared void or lapsed